Evidence map›Paper›PMID 38727284›Full record

ReviewCells2024

The Potential Reversible Transition between Stem Cells and Transient-Amplifying Cells: The Limbal Epithelial Stem Cell Perspective.

Sudhir Verma, Xiao Lin, Vivien J Coulson-Thomas

Abstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sudhir VermaCollege of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX 77204, USA.ORCID 0000-0002-2891-1987
Xiao LinCollege of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX 77204, USA.ORCID 0000-0002-5867-6455
Vivien J Coulson-ThomasCollege of Optometry, University of Houston, 4901 Calhoun Road, Houston, TX 77204, USA.ORCID 0000-0002-5848-0225

Funding

Hyaluronan in the limbal stem cell niche: from regulation of stem cell fate to translational applicationsR01EY029289 · NEI · UNIVERSITY OF HOUSTON · PI Vivien Jane Coulson-Thomas · 2018 to 2026
$3.0M
NEI NIH HHS R01 EY029289NEI NIH HHS R01EY029289
6 · The paper itself

Abstract

Stem cells (SCs) undergo asymmetric division, producing transit-amplifying cells (TACs) with increased proliferative potential that move into tissues and ultimately differentiate into a specialized cell type. Thus, TACs represent an intermediary state between stem cells and differentiated cells. In the cornea, a population of stem cells resides in the limbal region, named the limbal epithelial stem cells (LESCs). As LESCs proliferate, they generate TACs that move centripetally into the cornea and differentiate into corneal epithelial cells. Upon limbal injury, research suggests a population of progenitor-like cells that exists within the cornea can move centrifugally into the limbus, where they dedifferentiate into LESCs. Herein, we summarize recent advances made in understanding the mechanism that governs the differentiation of LESCs into TACs, and thereafter, into corneal epithelial cells. We also outline the evidence in support of the existence of progenitor-like cells in the cornea and whether TACs could represent a population of cells with progenitor-like capabilities within the cornea. Furthermore, to gain further insights into the dynamics of TACs in the cornea, we outline the most recent findings in other organ systems that support the hypothesis that TACs can dedifferentiate into SCs.

Indexed as

Cell DifferentiationEpithelium, CornealLimbus CorneaeStem CellsAnimalsCell ProliferationEpithelial CellsHumanscentrifugal movementcorneadedifferentiationlimbal epithelial stem cells (LESCs)progenitorsstem cellstransit-amplifying cells (TACs)

Identifiers

PMID38727284
PMCPMC11083486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.